Prevotella intermedia induces prostaglandin E2 via multiple signaling pathways

Journal of Dental Research

Volumn 90, Issue 1, 2011, Pages 121-127

  Guan, S M ^a   Fu, S M ^a   He, J J ^a   Zhang, M ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

cyclooxygenase 2; EP receptor; Prevotella intermedia; prostaglandin E2; signaling pathway

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; ENZYME INHIBITOR; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROTEIN KINASE C; PTGS2 PROTEIN, HUMAN; STRESS ACTIVATED PROTEIN KINASE; SULFONAMIDE;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; FIBROBLAST; HUMAN; METABOLISM; PERIODONTAL LIGAMENT; PHYSIOLOGY; PREVOTELLA INTERMEDIA; SIGNAL TRANSDUCTION; TIME;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; INDOMETHACIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NITROBENZENES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTAL LIGAMENT; PHOSPHATIDYLINOSITOL 3-KINASES; PREVOTELLA INTERMEDIA; PROTEIN KINASE C; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION; SULFONAMIDES; TIME FACTORS;

EID: 78650997245     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510382545     Document Type: Article

References (33)

1. Banu N., Buda A., Chell S., Elder D., Moorghen M., Paraskeva C., et al. (2007). Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy. Cell Prolif 40: 768-779.
2. Bodet C., Chandad F., Grenier D. (2006). Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect 8: 27-35.
3. Choi HC, Kim HS, Lee KY, Chang KC, Kang YJ (2008). NS-398, a selective COX-2 inhibitor, inhibits proliferation of IL-1beta-stimulated vascular smooth muscle cells by induction of HO-1. Biochem Biophys Res Commun 376: 753-757.
4. Chung YH, Chang EJ, Kim SJ, Kim HH, Kim HM, Lee SB, et al. (2006). Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. J Periodontal Res 41: 288-296.
5. DeWitt DL (1999). Cox-2-selective inhibitors: the new super aspirins. Mol Pharmacol 55: 625-631.
6. Eley BM, Cox SW (2003). Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid. Periodontol 2000 31: 105-124.
7. Fukushima H., Jimi E., Okamoto F., Motokawa W., Okabe K. (2005). IL-1-induced receptor activator of NF-kappa B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production. Bone 36: 267-275.
8. Guan SM, Shu L., Fu SM, Liu B., Xu XL, Wu JZ (2008). Prevotella intermedia induces matrix metalloproteinase-9 expression in human periodontal ligament cells. FEMS Microbiol Lett 283: 47-53.
9. Guan SM, Shu L., Fu SM, Liu B., Xu XL, Wu JZ (2009 a). Prevotella intermedia upregulates MMP-1 and MMP-8 expression in human periodontal ligament cells. FEMS Microbiol Lett 299: 214-222.
10. Guan SM, Zhang M., He JJ, Wu JZ (2009 b). Mitogen-activated protein kinases and phosphatidylinositol 3-kinase are involved in Prevotella intermedia- induced proinflammatory cytokines expression in human periodontal ligament cells Biochem Biophys Res Commun 386: 471-476.
11. Inoue H., Tsujisawa T., Fukuizumi T., Kawagishi S., Uchiyama C. (1999). SC-19220, a prostaglandin E2 antagonist, inhibits osteoclast formation by 1,25-dihydroxyvitamin D3 in cell cultures. J Endocrinol 161: 231-236.
12. Kanzaki H., Chiba M., Shimizu Y., Mitani H. (2002). Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis. J Bone Miner Res 17: 210-220.
13. Miyaura C., Kusano K., Masuzawa T., Chaki O., Onoe Y., Aoyagi M., et al. (1995). Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 10: 1365-1373.
14. Narumiya S., Sugimoto Y., Ushikubi F. (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226.
15. Nieminen R., Leinonen S., Lahti A., Vuolteenaho K., Jalonen U., Kankaanranta H., et al. (2005). Inhibitors of mitogen-activated protein kinases down-regulate COX-2 expression in human chondrocytes. Mediators Inflamm 2005: 249-255.
16. Noguchi K., Ishikawa I. (2007). The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 43: 85-101.
17. Noguchi K., Shitashige M., Yanai M., Morita I., Nishihara T., Murota S., et al. (1996). Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides. Inflammation 20: 555-568.
18. Noguchi K., Yanai M., Shitashige M., Nishihara T., Ishikawa I. (2000). Cyclooxygenase-2-dependent prostaglandin production by peripheral blood monocytes stimulated with lipopolysaccharides isolated from periodontopathogenic bacteria. J Periodontol 71: 1575-1582.
19. Noguchi K., Shitashige M., Endo H., Kondo H., Ishikawa I. (2002). Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts. J Periodontal Res 37: 29-36.
20. Noguchi K., Miyauchi M., Oka H., Komaki M., Somerman MJ, Takata T. (2007). Cyclooxygenase-2-dependent prostaglandin E(2) upregulates interleukin (IL)-1alpha-induced IL-6 generation in mouse cementoblasts. J Periodontol 78: 135-140.
21. Nukaga J., Kobayashi M., Shinki T., Song H., Takada T., Takiguchi T., et al. (2004). Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells. J Periodontol 75: 249-259.
22. Ogata S., Kubota Y., Yamashiro T., Takeuchi H., Ninomiya T., Suyama Y., et al. (2007). Signaling pathways regulating IL-1alpha-induced COX-2 expression. J Dent Res 86: 186-191.
23. Oka H., Miyauchi M., Sakamoto K., Moriwaki S., Niida S., Noguchi K., et al. (2007). PGE2 activates cementoclastogenesis by cementoblasts via EP4. J Dent Res 86: 974-979.
24. Ono K., Akatsu T., Murakami T., Kitamura R., Yamamoto M., Shinomiya N., et al. (2002). Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. J Bone Miner Res 17: 774-781.
25. Radi ZA, Khan NK (2005). Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res 54: 358-366.
26. Raisz LG (2001). Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med 110 (suppl 3A). 43-45.
27. Sakata M., Shiba H., Komatsuzawa H., Fujita T., Uchida Y., Yoshino H., et al. (2002). Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. Cytokine 18: 133-139.
28. Shoji M., Tanabe N., Mitsui N., Tanaka H., Suzuki N., Takeichi O., et al. (2006). Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts. Life Sci 78: 2012-2018.
29. Suzawa T., Miyaura C., Inada M., Maruyama T., Sugimoto Y., Ushikubi F., et al. (2000). The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141: 1554-1559.
30. Tanabe T., Tohnai N. (2002). Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 68-69: 95-114.
31. Tsujisawa T., Inoue H., Nishihara T. (2005). SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. J Bone Miner Res 20: 15-22.
32. Ueda N., Koide M., Ohguchi M., Ishihara Y., Noguchi T., Okahashi N., et al. (1998). Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. J Periodontal Res 33: 509-516.
33. Walton KL, Holt L., Sartor RB (2009). Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways. Am J Physiol Gastrointest Liver Physiol 296: G601 - G611.